mecamylamine and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide

mecamylamine has been researched along with n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crooks, PA; Dwoskin, LP; McConnell, MJ; Zhan, CG; Zheng, F1
Bardo, MT; Crooks, PA; Dwoskin, LP; Neugebauer, NM; Zhang, Z1
Bardo, MT; Crooks, PA; Dwoskin, LP; Papke, RL; Rahman, S; Zhang, Z1
Crooks, PA; Dhawan, GK; Dwoskin, LP; Siripurapu, KB; Smith, AM; Zhang, Z1

Other Studies

4 other study(ies) available for mecamylamine and n,n'-dodecane-1,12-diyl-bis-3-picolinium dibromide

ArticleYear
QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.
    Bioorganic & medicinal chemistry, 2009, Jul-01, Volume: 17, Issue:13

    Topics: Animals; Corpus Striatum; Dopamine; Linear Models; Models, Biological; Molecular Structure; Neural Networks, Computer; Nicotine; Nicotinic Antagonists; Quantitative Structure-Activity Relationship; Quaternary Ammonium Compounds; Rats; Receptors, Nicotinic

2009
Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
    Psychopharmacology, 2006, Volume: 184, Issue:3-4

    Topics: Animals; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Infusions, Intravenous; Injections, Subcutaneous; Male; Mecamylamine; Motivation; Motor Activity; Nicotine; Nicotinic Antagonists; Picolines; Premedication; Rats; Rats, Sprague-Dawley; Self Administration; Sucrose

2006
Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
    British journal of pharmacology, 2008, Volume: 153, Issue:4

    Topics: Acetylcholine; Animals; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mecamylamine; Membrane Potentials; Microdialysis; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Perfusion; Picolines; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recombinant Proteins; Time Factors; Ventral Tegmental Area; Xenopus laevis

2008
The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
    Biochemical pharmacology, 2009, Oct-01, Volume: 78, Issue:7

    Topics: Aconitine; Allosteric Regulation; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Picolines; Rats; Rats, Sprague-Dawley; Tritium

2009